Results 51 to 60 of about 64,509,941 (193)

Biologics Adoption in CRSwNP and the Associated Decline in Endoscopic Sinus Surgery: A Longitudinal Claims Database Study

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Biologic treatments were introduced for chronic rhinosinusitis with nasal polyps (CRSwNP) in 2019. Treatment algorithms for medically refractory CRSwNP remain open, with patients choosing among surgery, biologics, or both. Real‐world utilization of surgery and biologics remains incompletely characterized.
Stephanie Shintani Smith, Sam L. Kaefer, Harsh Duvvuru, Robert C. Kern, Brent A. Senior, Vijay R. Ramakrishnan   +5 more
wiley   +1 more source

Eosinophilic granulomatosis with polyangiitis-related myocarditis during mepolizumab therapy reveals a Th1/Th17-mediated vasculitic response

, 2022
Eosinophilic granulomatosis with polyangiitis-related myocarditis during mepolizumab therapy reveals a Th1/Th17-mediated vasculitic ...
Annunziato, Francesco, Tamburini, Carlo, Bello, Federica, Maggi, Laura, Prisco, Domenico, Emmi, Giacomo, Cosmi, Lorenzo   +6 more
core   +1 more source

A presentation of recurrent cerebral ischemic stroke in eosinophilic granulomatosis with polyangiitis: a case report

Journal of Medical Case Reports
Background Eosinophilic granulomatosis with polyangiitis is characterized as a small vessel vasculitis with the propensity to have a myriad of presentations due to the targeting of several different organ systems. More often than not, it is the pulmonary
Bryan Gregory, Ahmed Dawood Al Mahrizi, Harman Gill, Fatima Mossolem, Song Ang Peng, Randy Rueda, Eunseuk Lee   +6 more
doaj   +1 more source

Refractory diffuse alveolar hemorrhage caused by eosinophilic granulomatosis with polyangiitis in the absence of elevated biomarkers treated successfully by rituximab and mepolizumab: A case report

Respiratory Medicine Case Reports, 2019
Here we report on a 61-year-old man with refractory eosinophilic granulomatosis with polyangiitis (EGPA) who presented with dyspnea. Despite treatment with glucocorticoids, intravenous cyclophosphamide, and plasma exchange, his symptoms worsened despite ...
Akihiro Shiroshita, Kei Nakashima, Shinji Motojima, Masahiro Aoshima   +3 more
doaj   +1 more source

Pulmonary Involvement in Eosinophilic Granulomatosis with Polyangiitis. [PDF]

J Belg Soc Radiol
Teaching point: Air space opacities, either consolidation or ground glass, are the most frequent imaging finding in EGPA patients with pulmonary involvement, often bilateral and mostly peripheral or random in distribution.
Van Snick E, Mwewa T, Ilsen B.
europepmc   +5 more sources

Effective Performance of the 2022 American College of Rheumatology/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in Pediatric Patients: An ARChiVe Study

Arthritis &Rheumatology, EarlyView.
Objective To assess the 2022 American College of Rheumatology (ACR)/EULAR classification criteria for antineutrophil cytoplasmic antibody–associated vasculitis (AAV) in children with chronic small‐to‐medium vessel vasculitis. Methods A cohort of 574 patients, identified by physician's diagnosis (MD‐diagnosis) in A Registry of Childhood Vasculitis, was ...
David A. Cabral, Else S. Bosman, Nick McPhate, Simranpreet K. Mann, Kirandeep K. Toor, Kimberly A. Morishita, Raashid Luqmani, Michael W. Beresford, James Bistolarides, Sarah Campillo, Sirirat Charuvanij, Kathryn Cook, Paul Dancey, Marietta de Guzman, Samundeeswari Deepak, Barbara Eberhard, Melissa Elder, Samuel Gagne, Katie Harrison, Adam Huber, Archana Khan, Susan Kim, Marisa S. Klein‐Gitelman, Tzielan C. Lee, Suzanne C. Li, Neil Martin, Flora McErlane, L. Nandini Moorthy, Alvaro H. Orjuela, Jonathan Park, Phil Riley, Alan M. Rosenberg, Susan Shenoi, Vidya Sivaraman, Sodality Sutnga, Tamara Tanner, Stacey E. Tarvin, Marinka Twilt, Linda Wagner‐Weiner, Rae S. M. Yeung, Kelly L. Brown, for the ARChiVe Investigators Network within the PedVas Initiative   +41 more
wiley   +1 more source

Characteristics of study patients with eosinophilic granulomatosis with polyangiitis.

, 2018
Characteristics of study patients with eosinophilic granulomatosis with polyangiitis.
David Cuthbertson (188652), Nader A. Khalidi (188685), Peter A. Merkel (188721), Simon Carette (188665), Steven R. Ytterberg (188716), Kit Wong (5849114), Christian Pagnoux (676178), Paul A. Monach (188628), Rennie L. Rhee (5849108), Curry L. Koening (5849117), Larry W. Moreland (373814), Carol A. McAlear (5849120), Philip Seo (188695), Cecile T. J. Holweg (5849111), Carol A. Langford (188690), Ulrich Specks (972), Antoine G. Sreih (5849123)   +16 more
core   +1 more source

Polyps, grommets and eosinophilic granulomatosis with polyangiitis

, 2018
Objective:To explore the link between nasal polyposis, refractory otitis media with effusion and eosinophilic granulomatosis with polyangiitis.Methods:A retrospective observational study was carried out of patients diagnosed with refractory otitis media ...
D A Smyth, J E Fenton, W Hasan, F G Kavanagh   +3 more
core   +1 more source

An immunogenetic perspective of ANCA-associated vasculitides

Egyptian Rheumatology and Rehabilitation, 2022
Background Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are a group of small vessel vasculitides characterized by necrotizan vasculitis and inflammation.
A. Kocaaga, M. Kocaaga
doaj   +1 more source

New Insights into Pathogenesis and Treatment of ANCA-Associated Vasculitis: Autoantibodies and Beyond

Antibodies, 2023
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is a group of rare systemic diseases affecting small-caliber vessels. The damage caused by AAV mainly involves the lung and kidneys. AAV includes three different types: granulomatosis with
Marino Paroli, Chiara Gioia, Daniele Accapezzato   +2 more
doaj   +1 more source